GlassScriptPhysician profile
Ben Z Jacobs
NPI 1093740300
$7,340.44
in general payments reported to CMS, 2019-2025
26 companies · $887 in 2025
The $887 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $917 · 2020: $639 · 2021: $1,252 · 2022: $1,160 · 2023: $1,263 · 2024: $1,222 · 2025: $887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,272 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,271.83 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $2,034.21 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $1,851.60 | 2019-2025 | Myrbetriq, Xtandi |
| Pfizer INC. | $757.92 | 2019-2025 | |
| Abbvie INC. | $646.30 | 2019-2025 | |
| Urovant Sciences INC | $409.94 | 2021-2022 | |
| Tolmar Pharmaceuticals, INC. | $182.66 | 2019-2022 | |
| Tolmar, INC. | $178.57 | 2023-2024 | |
| Myovant Sciences INC. | $175.25 | 2021-2022 | |
| Janssen Biotech, INC. | $126.94 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $106.30 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $101.62 | 2021 | |
| Comsort, INC | $100.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.98 | 2020-2022 | |
| Myriad Genetic Laboratories, INC. | $90.87 | 2021-2022 | |
| Urogen Pharma, INC. | $75.16 | 2023 | Jelmyto |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abc Home Medical Supply, INC. | $67.04 | 2024-2025 | |
| Hollister Incorporated | $66.85 | 2021-2024 | Infyna Chic, Vapro, Vapro Pocket |
| Dendreon Pharmaceuticals LLC | $60.45 | 2019-2020 | |
| Coloplast Corp | $58.75 | 2019 | |
| Neotract INC. | $29.88 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.55 | 2024 | |
| Verity Pharmaceuticals INC. | $22.73 | 2022 | |
| Blue Earth Diagnostics | $21.16 | 2021 | |
| Foundation Medicine, INC. | $21.13 | 2021 | |
| Antares Pharma, INC. | $17.00 | 2021 | |
| Mission Pharmacal Company | $12.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.